Acumen Pharmaceuticals Balance Sheet (2020-2026) | ABOS

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Receivables - Accured (Quarter)
0.23M0.05M
Assets
Current Assets
Cash & Equivalents (Quarter)
36.80M134.80M122.16M108.76M111.07M157.54M130.10M78.00M77.25M94.92M66.20M46.93M67.95M32.80M35.30M30.16M36.81M46.83M53.99M51.40M
Receivables - Net (Quarter)
0.11M0.11M
Receivables - Other (Quarter)
0.23M0.19M0.11M0.27M0.34M0.38M0.32M0.38M0.62M0.77M
Receivables (Quarter)
0.11M0.11M
Prepaid Assets (Quarter)
1.65M4.84M0.14M3.01M1.14M2.37M0.24M3.62M4.66M0.18M3.82M0.40M0.41M0.46M7.24M5.80M5.04M5.54M5.74M5.00M
Current Assets (Quarter)
70.57M204.91M198.66M192.10M191.05M202.56M180.33M144.03M149.54M218.60M246.62M255.83M266.92M207.63M178.31M154.95M148.40M132.15M122.25M133.09M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.01M0.01M0.04M0.05M0.11M0.14M0.17M0.15M0.14M0.12M0.12M0.12M0.10M0.09M
Long-Term Investments (Quarter)
29.91M31.62M27.66M20.00M15.84M43.42M27.31M67.27M62.55M44.11M20.91M58.55M59.97M48.80M22.80M9.44M
Long-Term Deferred Tax (Quarter)
2.35M
Other Non-Current Assets (Quarter)
0.01M0.01M0.01M0.08M0.11M0.15M0.20M0.21M0.19M0.23M0.23M0.42M0.17M0.49M0.23M0.23M0.23M0.35M0.23M
Non-Current Assets (Quarter)
2.37M29.94M31.67M27.99M20.62M0.70M16.26M43.83M27.87M67.77M63.51M45.14M22.00M59.34M60.69M49.53M23.49M10.07M0.58M0.54M
Assets (Quarter)
72.94M234.85M230.33M220.09M211.68M203.26M196.59M187.86M177.41M286.37M310.12M300.97M288.91M266.98M238.99M204.48M171.90M142.22M122.83M133.63M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.91M0.38M1.09M1.22M1.71M2.08M1.64M0.76M2.03M1.36M1.38M3.08M4.21M2.34M5.65M1.06M2.10M0.68M0.55M1.66M
Notes Payables (Quarter)
3.60M8.77M14.12M
Payables (Quarter)
2.91M0.38M1.09M1.22M1.71M2.08M1.64M0.76M2.03M1.36M1.38M3.08M4.21M2.34M5.65M1.06M2.10M4.28M9.32M15.78M
Accumulated Expenses (Quarter)
1.61M1.11M3.91M2.58M3.28M4.40M3.35M2.75M2.37M3.17M6.45M2.90M4.00M4.93M6.62M6.71M11.65M7.79M10.07M5.27M
Other Accumulated Expenses (Quarter)
0.05M0.12M0.20M0.10M0.10M0.04M
Short term Debt (Quarter)
3.60M8.77M14.12M
Current Leases (Quarter)
0.14M0.14M0.13M0.10M0.07M0.03M0.00M0.76M0.12M0.13M
Total Current Liabilities (Quarter)
5.15M3.94M5.13M6.61M7.81M8.78M8.53M6.10M12.97M8.47M15.37M19.91M27.61M19.32M24.86M21.96M30.01M29.23M
Non-Current Liabilities
Non-Current Debt (Quarter)
29.90M30.21M29.38M29.67M29.42M29.53M29.88M27.05M22.40M16.92M
Preferred Stock Liabilities (Quarter)
174.50M
Operating Leases (Quarter)
0.06M0.17M0.13M0.28M0.25M0.22M0.18M
Other Non-Current Liabilities (Quarter)
0.28M0.15M0.11M0.08M0.04M
Total Non-Current Liabilities (Quarter)
42.87M57.03M48.84M54.74M49.01M52.40M
Total Liabilities (Quarter)
4.52M1.49M5.15M4.00M5.16M6.61M7.81M8.78M8.53M6.10M43.15M38.93M44.97M49.77M57.18M48.96M54.82M49.05M52.40M46.15M
Shareholder's Equity
Total Debt (Quarter)
29.90M30.21M29.38M29.67M29.42M29.53M29.88M30.65M31.16M31.05M
Common Equity (Quarter)
-106.08M233.36M225.18M216.09M206.52M196.65M188.78M179.09M168.87M280.27M266.97M262.03M243.95M217.20M181.82M155.52M117.08M93.17M70.43M87.48M
Liabilities and Shareholders Equity (Quarter)
72.94M234.85M230.33M220.09M211.68M203.26M196.59M187.86M177.41M286.37M310.12M300.97M288.91M266.98M238.99M204.48M171.90M142.22M122.83M133.63M
Retained Earnings (Quarter)
-115.32M-119.22M-127.57M-136.70M354.33M-157.56M-0.75M-181.70M-0.65M-206.30M-222.80M-237.67M-0.16M-288.00M-0.05M-353.90M-394.87M0.11M-446.50M-467.20M
Treasury Shares (Quarter)
28.23M0.33M0.33M0.33M0.33M1.42M1.41M1.41M1.35M1.85M1.92M1.91M1.91M2.76M